World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

FORMULATION AND EVALUATION OF ORAL PULSATILE DRUG DELIVARY SYSTEM OF CANDESARTAN CILEXETIL

*Dr. Bharathi A., Bojadla Vanaja and Chandra Sekhar Naik D.

ABSTRACT

Pulsatile Drug Delivery systems (PDDS) is a novel method, it is basically time-controlled drug delivery systems in which the system controls the lag time and drug is released in an immediate or extended fashion. The present investigation was conducted for formulation and evaluation of pulsatile release tablets of candesartancilexetil for the treatment of cardiovascular diseases. The compression coated tablets consisted of a core tablet containing drug with syntheticsuperdisintegrant, which was further coated by erodible outer layer consisted of HPMC K4 and HPMC K100. After carrying outpreformulation studies the formulated tablets were evaluated for post post-compression parameters like weight variation, thickness, hardness, friability, drug content and in-vitro study of drug release. The best formulation was selected on the basis of post-compression parameters and was subjected to accelerated stability studies for 3 month. Amongst 6 formulations prepared, F6 produced convincing results with a maximum cumulative drug release of 99.1% in 8 hours. Also the formulation didn’t show any significant changes during 3 month period of stress testing. By virtue of its release pattern and delivering the drug at the right time, right place and in right amounts, the developed delivery system holds good promises of benefiting the patients suffering from hypertension.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR